| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $47.1M | +25.9% |
| SG&A Expense | $15.9M | +0.9% |
| Operating Income | -$63.1M | -18.5% |
| Interest Expense | $0 | -100.0% |
| Income Tax | $0 | — |
| Net Income | -$62.5M | -22.8% |
| EPS (Basic) | -$2.60 | -2.4% |
| EPS (Diluted) | -$2.60 | -2.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.6M | +14.2% |
| Short-term Investments | $0 | -100.0% |
| Current Assets | $37.4M | -56.7% |
| Total Assets | $43.1M | -52.7% |
| Current Liabilities | $10.3M | +43.2% |
| Long-term Debt | $0 | — |
| Total Liabilities | $10.8M | +48.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$51.2M | -11.8% |
| Capital Expenditures | $1.3M | -46.6% |
| Investing Cash Flow | $50.3M | +193.5% |
| Financing Cash Flow | $5.2M | -95.9% |
| Free Cash Flow | -$52.4M | -9.0% |
| Stockholders' Equity |
| $32.3M |
| -61.4% |